Skip to main content
. 2023 Aug;85(3):402–427. doi: 10.18999/nagjms.85.3.402

Fig. 3.

Fig. 3

Meta-regression scatter plot of the clinical remission rate based on the prior use of anti-tumor necrosis factor agents